Useful links
Microsoft office 365 disruptions
There is a global Microsoft 365 service degradation affecting University access to Outlook email and, in some cases, other M365 applications. You are advised to use alternative communication channels. Existing enquiries submitted through the Services Portal continue to be progressed, with updates remaining accessible to students. We encourage students to regularly check their enquiries via the Portal for the latest information and outcomes, while Outlook services remain unavailable. If you need support, contact the University Service Desk on 9351 2000, Student Centre on 1800 SYD UNI (1800 793 864) or Protective Services on 1800 SYD HLP (1800 793 457). Students can connect with Student Wellbeing via the Student Wellbeing Portal.
Unit of study_
PHAR7825: Therapeutic Product Vigilance
2027 unit information
Vigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects resulting from the use of a therapeutic product. This unit will cover the identification and quantification of risk associated with medicinal products, recognition, and interpretation of adverse effects and their underlying toxicopathology and pharmacology. Students will learn to write and interpret several documents associated with product vigilance including Risk Management Plans (RMPs), Periodic BenefitRisk Evaluation Report (PBRER), Development Safety Update Reports (DSURs). The international and Australian guidelines for adverse event reporting and the role of the qualified person and compliance will be addressed in the course.
Unit details and rules
Managing faculty or University school:
Medicine and Health
| Study level | Postgraduate |
|---|---|
| Academic unit | Pharmacy |
| Credit points | 6 |
|
Prerequisites:
?
|
None |
|---|---|
|
Corequisites:
?
|
None |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
None |
At the completion of this unit, you should be able to:
- LO1. Understand the requirements for post-marketing compliance and product vigilance activities and their contribution to the safety of a therapeutic product
- LO2. Analyse risks of therapeutic products
- LO3. Perform activities associated with the role of the vigilance and product safety specialist
- LO4. Integrate knowledge, skills and experience of product vigilance and risk profiles using reflective practice
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
| Session | MoA ? | Location | Outline ? |
|---|---|---|---|
|
Semester 2 2027
|
Online | Camperdown/Darlington, Sydney |
Outline unavailable
|
Find your current year census dates
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
Disclaimer
Important: the University of Sydney regularly reviews units of study and reserves the right to change the units of study available annually. To stay up to date on available study options, including unit of study details and availability, refer to the relevant handbook.
To help you understand common terms that we use at the University, we offer an online glossary.